文献速递心脑血管急症

血清钙水平相关基因变异与冠状动脉疾病及心肌梗死的关联

Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction.
PubMed 文献 · JAMA · 2017-01-01
一句话结论孟德尔随机化研究显示,遗传预测的血清钙水平每升高0.5 mg/dL,冠状动脉疾病风险增加25%,心肌梗死风险增加24%。

该研究采用孟德尔随机化方法,利用血清钙水平全基因组关联荟萃分析(N最高达61079)中筛选的6个单核苷酸多态性(SNPs),在CardiogramplusC4D联盟的1000基因组基础全基因组关联荟萃分析(N最高达184305,含60801例冠状动脉疾病病例和123504例非病例)中评估遗传预测的血清钙水平与冠状动脉疾病及心肌梗死的关联。结果显示,遗传预测的血清钙水平每升高0.5 mg/dL(约1个标准差),冠状动脉疾病比值比为1.25(95%CI 1.08-1.45;P=0.003),心肌梗死比值比为1.24(95%CI 1.05-1.46;P=0.009)。作者结论认为,遗传易感性导致血清钙水平升高与冠状动脉疾病和心肌梗死风险增加相关,但终生遗传暴露于较高血清钙水平所关联的冠状动脉疾病风险能否转化为短期至中期补钙相关的风险尚不清楚。

要点

  • 在184305名个体(60801例冠状动脉疾病病例,约70%合并心肌梗死;123504例非病例)中,遗传预测的血清钙水平每升高0.5 mg/dL(约1个标准差),冠状动脉疾病比值比为1.25(95%CI 1.08-1.45;P=0.003)。
  • 同一分析中,遗传预测的血清钙水平每升高0.5 mg/dL,心肌梗死比值比为1.24(95%CI 1.05-1.46;P=0.009)。
  • 研究所用的6个与血清钙水平相关的SNPs无多效性关联,估计可解释约0.8%的血清钙水平变异。
  • 作者结论指出,遗传易感性导致血清钙水平升高与冠状动脉疾病和心肌梗死风险增加相关。
  • 作者同时指出,终生遗传暴露于较高血清钙水平所关联的冠状动脉疾病风险能否转化为短期至中期补钙相关的风险尚不清楚。

适用人群与场景

  • 孟德尔随机化分析样本为184305名个体,包括60801例冠状动脉疾病病例(约70%合并心肌梗死)和123504例非病例,基线数据收集自1948年,人群来自全球各地。

研究设计与关键结果

  • 研究设计为孟德尔随机化分析,利用血清钙水平全基因组关联荟萃分析(N最高达61079)中筛选的6个与血清钙水平相关且无多效性关联的SNPs,在CardiogramplusC4D联盟的1000基因组基础全基因组关联荟萃分析(N最高达184305)中评估遗传预测的血清钙水平与冠状动脉疾病及心肌梗死的关联。
  • 每个SNP与冠状动脉疾病及心肌梗死的关联按其与血清钙水平的关联进行加权,采用逆方差加权荟萃分析合并估计值。
  • 6个SNPs估计可解释约0.8%的血清钙水平变异。
  • 逆方差加权荟萃分析显示,遗传预测的血清钙水平每升高0.5 mg/dL(约1个标准差),冠状动脉疾病比值比为1.25(95%CI 1.08-1.45;P=0.003)。
  • 遗传预测的血清钙水平每升高0.5 mg/dL,心肌梗死比值比为1.24(95%CI 1.05-1.46;P=0.009)。

证据类型、等级与局限

  • 证据类型为孟德尔随机化研究。
  • 局限:作者指出,终生遗传暴露于较高血清钙水平所关联的冠状动脉疾病风险能否转化为短期至中期补钙相关的风险尚不清楚。

对床旁实践的改变

  • 作者结论认为,遗传易感性导致血清钙水平升高与冠状动脉疾病和心肌梗死风险增加相关。
  • 作者指出,终生遗传暴露于较高血清钙水平所关联的冠状动脉疾病风险能否转化为短期至中期补钙相关的风险尚不清楚。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Serum calcium has been associated with cardiovascular disease in observational studies and evidence from randomized clinical trials indicates that calcium supplementation, which raises serum calcium levels, may increase the risk of cardiovascular events, particularly myocardial infarction.

OBJECTIVE: To evaluate the potential causal association between genetic variants related to elevated serum calcium levels and risk of coronary artery disease (CAD) and myocardial infarction using mendelian randomization.

DESIGN, SETTING, AND PARTICIPANTS: The analyses were performed using summary statistics obtained for single-nucleotide polymorphisms (SNPs) identified from a genome-wide association meta-analysis of serum calcium levels (N = up to 61 079 individuals) and from the Coronary Artery Disease Genome-wide Replication and Meta-analysis Plus the Coronary Artery Disease Genetics (CardiogramplusC4D) consortium's 1000 genomes-based genome-wide association meta-analysis (N = up to 184 305 individuals) that included cases (individuals with CAD and myocardial infarction) and noncases, with baseline data collected from 1948 and populations derived from across the globe. The association of each SNP with CAD and myocardial infarction was weighted by its association with serum calcium, and estimates were combined using an inverse-variance weighted meta-analysis.

EXPOSURES: Genetic risk score based on genetic variants related to elevated serum calcium levels.

MAIN OUTCOMES AND MEASURES: Co-primary outcomes were the odds of CAD and myocardial infarction.

RESULTS: Among the mendelian randomized analytic sample of 184 305 individuals (60 801 CAD cases [approximately 70% with myocardial infarction] and 123 504 noncases), the 6 SNPs related to serum calcium levels and without pleiotropic associations with potential confounders were estimated to explain about 0.8% of the variation in serum calcium levels. In the inverse-variance weighted meta-analysis (combining the estimates of the 6 SNPs), the odds ratios per 0.5-mg/dL increase (about 1 SD) in genetically predicted serum calcium levels were 1.25 (95% CI, 1.08-1.45; P = .003) for CAD and 1.24 (95% CI, 1.05-1.46; P = .009) for myocardial infarction.

CONCLUSIONS AND RELEVANCE: A genetic predisposition to higher serum calcium levels was associated with increased risk of CAD and myocardial infarction. Whether the risk of CAD associated with lifelong genetic exposure to increased serum calcium levels can be translated to a risk associated with short-term to medium-term calcium supplementation is unknown.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Larsson SC, Burgess S, Michaëlsson K, et al. Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction. JAMA. 2017. PMID: 28742912. doi:10.1001/jama.2017.8981

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。